We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
LJAC
251
L.J. Altfest & Co
New York
$1.53M +$26.1K +343 +2%
RW
252
Rand Wealth
Maryland
$1.52M – – –
RGC
253
Roberts, Glore & Co
Illinois
$1.51M -$12.9K -170 -0.9%
Nomura Asset Management
254
Nomura Asset Management
Japan
$1.5M +$22.8K +300 +2%
US Bancorp
255
US Bancorp
Minnesota
$1.5M -$270K -3,543 -16%
TNB
256
Thomasville National Bank
Georgia
$1.47M +$390K +5,117 +40%
TRSOTSOK
257
Teachers Retirement System of the State of Kentucky
Kentucky
$1.47M -$122K -1,600 -8%
B
258
BP
United Kingdom
$1.47M +$1.37M +18,000 New
HNB
259
Huntington National Bank
Ohio
$1.44M -$291K -3,818 -18%
TAM
260
Trillium Asset Management
Massachusetts
$1.44M +$1.34M +17,625 New
IRF
261
IBM Retirement Fund
New York
$1.43M -$12.3K -161 -1%
Truist Financial
262
Truist Financial
North Carolina
$1.42M +$285K +3,744 +27%
Calamos Advisors
263
Calamos Advisors
Illinois
$1.42M +$168K +2,201 +14%
EVM
264
Eaton Vance Management
Massachusetts
$1.4M -$375K -4,928 -22%
MOACM
265
Mutual of America Capital Management
New York
$1.35M -$70.4K -924 -5%
NMERB
266
New Mexico Educational Retirement Board
New Mexico
$1.34M +$45.7K +600 +4%
QIM
267
Quantitative Investment Management
Virginia
$1.32M -$1.06M -13,900 -46%
Commonwealth Equity Services
268
Commonwealth Equity Services
Massachusetts
$1.31M +$80.6K +1,058 +7%
KCM
269
Kempner Capital Management
Texas
$1.3M – – –
TU
270
TDAM USA
Ontario, Canada
$1.23M -$86.2K -1,132 -7%
GS
271
GAM Systematic
United Kingdom
$1.23M +$319K +4,184 +38%
AAIM
272
American Assets Investment Management
California
$1.22M – – –
CT
273
Coastline Trust
Rhode Island
$1.22M -$52.5K -690 -4%
BTW
274
Boston Trust Walden
Massachusetts
$1.21M -$68.5K -900 -6%
WAM
275
World Asset Management
Michigan
$1.21M -$2.06K -27 -0.2%
9 10
11
12 13

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.